Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Venus Remedies Limited - Product Pipeline Review - 2014

Published: Jul-2014 | Format: PDF | Global Markets Direct | Number of pages: 23 | Code: MRS - 1003

This report provides comprehensive information on the current therapeutic developmental pipeline of Venus Remedies Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of Venus Remedies Limited including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Venus Remedies Limiteds human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones 
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement 
Latest news and deals relating to the Venus Remedies Limiteds pipeline products

Reasons to buy


Evaluate Venus Remedies Limiteds strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Venus Remedies Limited in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Venus Remedies Limiteds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Venus Remedies Limited and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Venus Remedies Limited
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Venus Remedies Limited and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table of Contents


Table of Contents 2

List of Tables 3
List of Figures 3
Venus Remedies Limited Snapshot 4
Venus Remedies Limited Overview 4
Key Information 4
Key Facts 4
Venus Remedies Limited - Research and Development Overview 5
Key Therapeutic Areas 5
Venus Remedies Limited - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Combination Treatment Modalities 9
Venus Remedies Limited - Pipeline Products Glance 10
Venus Remedies Limited - Late Stage Pipeline Products 10
Pre-Registration Products/Combination Treatment Modalities 10
Venus Remedies Limited - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Venus Remedies Limited - Drug Profiles 12
(ceftriaxone sodium + sulbactam sodium+ edetate sodium) 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
(ceftriaxone + tazobactam) 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
VRP-008 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Venus Remedies Limited - Pipeline Analysis 15
Venus Remedies Limited - Pipeline Products by Target 15
Venus Remedies Limited - Pipeline Products by Route of Administration 16
Venus Remedies Limited - Pipeline Products by Molecule Type 17
Venus Remedies Limited - Pipeline Products by Mechanism of Action 18
Venus Remedies Limited - Recent Pipeline Updates 19
Venus Remedies Limited - Dormant Projects 20
Genexine, Inc. - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21

Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23


List of Tables

Venus Remedies Limited, Key Information 4
Venus Remedies Limited, Key Facts 4
Venus Remedies Limited - Pipeline by Indication, 2014 6
Venus Remedies Limited - Pipeline by Stage of Development, 2014 7
Venus Remedies Limited - Monotherapy Products in Pipeline, 2014 8
Venus Remedies Limited - Combination Treatment Modalities in Pipeline, 2014 9
Venus Remedies Limited - Pre-Registration, 2014 10
Venus Remedies Limited - Preclinical, 2014 11
Venus Remedies Limited - Pipeline by Target, 2014 15
Venus Remedies Limited - Pipeline by Route of Administration, 2014 16
Venus Remedies Limited - Pipeline by Molecule Type, 2014 17
Venus Remedies Limited - Pipeline Products by Mechanism of Action, 2014 18
Venus Remedies Limited - Recent Pipeline Updates, 2014 19
Venus Remedies Limited - Dormant Developmental Projects,2014 20
Venus Remedies Limited, Subsidiaries 21


List of Figures

Venus Remedies Limited - Pipeline by Top 10 Indication, 2014 6
Venus Remedies Limited - Pipeline by Stage of Development, 2014 7
Venus Remedies Limited - Combination Treatment Modalities in Pipeline, 2014 9
Venus Remedies Limited - Pipeline by Top 10 Target, 2014 15
Venus Remedies Limited - Pipeline by Top 10 Molecule Type, 2014 17
Venus Remedies Limited - Pipeline Products by Top 10 Mechanism of Action, 2014 18 

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing